KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Amortization - Intangibles: 2011-2017

Historic Amortization - Intangibles for TherapeuticsMD (TXMD) over the last 5 years, with Dec 2017 value amounting to $7,699.

  • TherapeuticsMD's Amortization - Intangibles fell 66.67% to $32,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $406,000, marking a year-over-year decrease of 3.98%. This contributed to the annual value of $7,699 for FY2017, which is 28.87% down from last year.
  • As of FY2017, TherapeuticsMD's Amortization - Intangibles stood at $7,699, which was down 28.87% from $10,824 recorded in FY2016.
  • In the past 5 years, TherapeuticsMD's Amortization - Intangibles ranged from a high of $17,442 in FY2015 and a low of $7,699 during FY2017.
  • Moreover, its 3-year median value for Amortization - Intangibles was $10,824 (2016), whereas its average is $11,988.
  • Data for TherapeuticsMD's Amortization - Intangibles shows a maximum YoY crashed of 37.94% (in 2016) over the last 5 years.
  • Yearly analysis of 3 years shows TherapeuticsMD's Amortization - Intangibles stood at $17,442 in 2015, then plummeted by 37.94% to $10,824 in 2016, then fell by 28.87% to $7,699 in 2017.